Lumen-apposing metal stents for the treatment of benign gastrointestinal tract strictures: a single-center experience and proposed treatment algorithm.
Benign gastrointestinal strictures
Lumen-apposing metal stents
Stent
Journal
Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
received:
16
04
2022
accepted:
11
10
2022
pubmed:
2
11
2022
medline:
21
3
2023
entrez:
1
11
2022
Statut:
ppublish
Résumé
Lumen-apposing metal stents (LAMS) are an alternative therapeutic option for benign gastrointestinal (GI) tract strictures. Our study aimed to evaluate the safety and efficacy of LAMS for the management of benign GI strictures. Consecutive patients who underwent a LAMS placement for benign luminal GI strictures at a tertiary care center between January 2014 and July 2021 were reviewed. Primary outcomes included technical success, early clinical success, and adverse events (AEs). Other outcomes included rates of stent migration and re-intervention after LAMS removal. One hundred and nine patients who underwent 128 LAMS placements (67.9% female, mean age of 54.3 ± 14.2 years) were included, and 70.6% of the patients had failed prior endoscopic treatments. The majority of strictures (83.5%) were anastomotic, and the most common stricture site was the gastrojejunal anastomosis (65.9%). Technical success was achieved in 100% of procedures, while early clinical success was achieved in 98.4%. The overall stent-related AE rate was 25%. The migration rate was 27.3% (35/128). Of these, five stents were successfully repositioned endoscopically. The median stent dwell time was 119 days [interquartile range (IQR) 68-189 days], and the median follow-up duration was 668.5 days [IQR: 285.5-1441.5 days]. The re-intervention rate after LAMS removal was 58.3%. LAMS is an effective therapeutic option for benign GI strictures, offering high technical and early clinical success. However, the re-intervention rate after LAMS removal was high. In select cases, using LAMS placement as destination therapy with close surveillance is a reasonable option.
Sections du résumé
BACKGROUND
Lumen-apposing metal stents (LAMS) are an alternative therapeutic option for benign gastrointestinal (GI) tract strictures. Our study aimed to evaluate the safety and efficacy of LAMS for the management of benign GI strictures.
METHODS
Consecutive patients who underwent a LAMS placement for benign luminal GI strictures at a tertiary care center between January 2014 and July 2021 were reviewed. Primary outcomes included technical success, early clinical success, and adverse events (AEs). Other outcomes included rates of stent migration and re-intervention after LAMS removal.
RESULTS
One hundred and nine patients who underwent 128 LAMS placements (67.9% female, mean age of 54.3 ± 14.2 years) were included, and 70.6% of the patients had failed prior endoscopic treatments. The majority of strictures (83.5%) were anastomotic, and the most common stricture site was the gastrojejunal anastomosis (65.9%). Technical success was achieved in 100% of procedures, while early clinical success was achieved in 98.4%. The overall stent-related AE rate was 25%. The migration rate was 27.3% (35/128). Of these, five stents were successfully repositioned endoscopically. The median stent dwell time was 119 days [interquartile range (IQR) 68-189 days], and the median follow-up duration was 668.5 days [IQR: 285.5-1441.5 days]. The re-intervention rate after LAMS removal was 58.3%.
CONCLUSIONS
LAMS is an effective therapeutic option for benign GI strictures, offering high technical and early clinical success. However, the re-intervention rate after LAMS removal was high. In select cases, using LAMS placement as destination therapy with close surveillance is a reasonable option.
Identifiants
pubmed: 36316581
doi: 10.1007/s00464-022-09715-8
pii: 10.1007/s00464-022-09715-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2133-2142Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Kochhar R, Poornachandra KS (2010) Intralesional steroid injection therapy in the management of resistant gastrointestinal strictures. World J Gastrointest Endosc 2:61–68
doi: 10.4253/wjge.v2.i2.61
pubmed: 21160692
pmcid: 2999060
Larson B, Adler DG (2019) Lumen-apposing metal stents for gastrointestinal luminal strictures: current use and future directions. Ann Gastroenterol 32:141–146
pubmed: 30837786
Bazerbachi F, Heffley JD, Abu Dayyeh BK, Nieto J, Vargas EJ, Sawas T, Zaghlol R, Buttar NS, Topazian MD, Wong Kee Song LM, Levy M, Keilin S, Cai Q, Willingham FF (2017) Safety and efficacy of coaxial lumen-apposing metal stents in the management of refractory gastrointestinal luminal strictures: a multicenter study. Endosc Int Open 5:E861-e867
doi: 10.1055/s-0043-114665
pubmed: 28924591
pmcid: 5595583
Jain D, Patel U, Ali S, Sharma A, Shah M, Singhal S (2018) Efficacy and safety of lumen-apposing metal stent for benign gastrointestinal stricture. Ann Gastroenterol 31:425–438
pubmed: 29991887
pmcid: 6033762
Kochhar R, Kochhar S (2010) Endoscopic balloon dilation for benign gastric outlet obstruction in adults. World J Gastroint Endosc 2:29–35
doi: 10.4253/wjge.v2.i1.29
Santos-Fernandez J, Paiji C, Shakhatreh M, Becerro-Gonzalez I, Sanchez-Ocana R, Yeaton P, Samarasena J, Perez-Miranda M (2017) Lumen-apposing metal stents for benign gastrointestinal tract strictures: an international multicenter experience. World J Gastroint Endosc 9:571–578
doi: 10.4253/wjge.v9.i12.571
Hirdes MM, Siersema PD, Vleggaar FP (2012) A new fully covered metal stent for the treatment of benign and malignant dysphagia: a prospective follow-up study. Gastrointest Endosc 75:712–718
doi: 10.1016/j.gie.2011.11.036
pubmed: 22284093
Ham YH, Kim GH (2014) Plastic and biodegradable stents for complex and refractory benign esophageal strictures. Clin Endosc 47:295–300
doi: 10.5946/ce.2014.47.4.295
pubmed: 25133114
pmcid: 4130882
Spaander MCW, van der Bogt RD, Baron TH, Albers D, Blero D, de Ceglie A, Conio M, Czakó L, Everett S, Garcia-Pagán JC, Ginès A, Jovani M, Repici A, Rodrigues-Pinto E, Siersema PD, Fuccio L, van Hooft JE (2021) Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2021. Endoscopy 53:751–762
doi: 10.1055/a-1475-0063
pubmed: 33930932
Suzuki T, Siddiqui A, Taylor LJ, Cox K, Hasan RA, Laique SN, Mathew A, Wrobel P, Adler DG (2016) Clinical outcomes, efficacy, and adverse events in patients undergoing esophageal stent placement for benign indications: a large multicenter study. J Clin Gastroenterol 50:373–378
doi: 10.1097/MCG.0000000000000500
pubmed: 26905604
Little AG, Naunheim KS, Ferguson MK, Skinner DB (1988) Surgical management of esophageal structures. Ann Thorac Surg 45:144–147
doi: 10.1016/S0003-4975(10)62425-3
pubmed: 3341821
Jue TL, Storm AC, Naveed M, Fishman DS, Qumseya BJ, McRee AJ, Truty MJ, Khashab MA, Agrawal D, Al-Haddad M, Amateau SK, Buxbaum JL, Calderwood AH, DeWitt J, DiMaio CJ, Fujii-Lau LL, Gurudu SR, Jamil LH, Kwon RS, Law JK, Lee JK, Pawa S, Sawhney MS, Thosani NC, Yang J, Wani SB (2021) ASGE guideline on the role of endoscopy in the management of benign and malignant gastroduodenal obstruction. Gastrointest Endosc 93:309-322.e304
doi: 10.1016/j.gie.2020.07.063
pubmed: 33168194
Sharma P, McCarty TR, Chhoda A, Costantino A, Loeser C, Muniraj T, Ryou M, Thompson CC (2020) Alternative uses of lumen apposing metal stents. World J Gastroenterol 26:2715–2728
doi: 10.3748/wjg.v26.i21.2715
pubmed: 32550749
pmcid: 7284179
Adler DG, Lanke G (2020) Clinical update on the role of EUS in pelvic abscess. Pract Gastroenterol 44:32–41
Mansoor MS, Tejada J, Parsa NA, Yoon E, Hida S (2018) Off label use of lumen-apposing metal stent for persistent gastro-jejunal anastomotic stricture. World J Gastroint Endosc 10:117–120
doi: 10.4253/wjge.v10.i6.117
Bazerbachi F, Visrodia KH, Mavrogenis G, Song LMWK, Buttar NS (2020) Extrabiliary applications of fully covered antimigration biliary metal stents. VideoGIE 5:437–441
doi: 10.1016/j.vgie.2020.05.015
pubmed: 32954110
pmcid: 7483763
Cotton PB, Eisen GM, Aabakken L, Baron TH, Hutter MM, Jacobson BC, Mergener K, Nemcek A Jr, Petersen BT, Petrini JL, Pike IM, Rabeneck L, Romagnuolo J, Vargo JJ (2010) A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 71:446–454
doi: 10.1016/j.gie.2009.10.027
pubmed: 20189503
Rodrigues-Pinto E, Baron TH (2016) Evaluation of the AXIOS stent for the treatment of pancreatic fluid collections. Expert Rev Med Dev 13:793–805
doi: 10.1080/17434440.2016.1222898
Gerzic ZB, Knezevic JB, Milicevic MN, Jovanovic BK (1990) Esophagocoloplasty in the management of postcorrosive strictures of the esophagus. Ann Surg 211:329–336
doi: 10.1097/00000658-199003000-00004
pubmed: 2310239
pmcid: 1358439
Yang D, Nieto JM, Siddiqui A, Riff BP, DiMaio CJ, Nagula S, Ismail AM, Ngamreungphong S, Khashab MA, Wagh MS, Tzimas D, Buscaglia JM, Strand DS, Wang AY, Chauhan SS, Forsmark CE, Draganov PV (2017) Lumen-apposing covered self-expandable metal stents for short benign gastrointestinal strictures: a multicenter study. Endoscopy 49:327–333
doi: 10.1055/s-0042-122779
pubmed: 28114688
Hakim S, Khan Z, Shrivastava A, Koroglu E, Patil P, Akyuz F, Akyuz U, Ramireddy S, Badillo R, DaVee T, Thosani N (2021) Endoscopic Gastrointestinal Anastomosis Using Lumen-apposing Metal Stent (LAMS) for benign or malignant etiologies: a systematic review and meta-analysis. J Clin Gastroenterol 55:e56–e65
pubmed: 33060441
Dan DT, Gannavarapu B, Lee JG, Chang K, Muthusamy VR (2014) Removable esophageal stents have poor efficacy for the treatment of refractory benign esophageal strictures (Rbes). Dis Esophagus 27:511–517
doi: 10.1111/j.1442-2050.2012.01432.x
pubmed: 23121426
Fujii LL, Bonin EA, Baron TH, Gostout CJ, Wong Kee Song LM (2013) Utility of an endoscopic suturing system for prevention of covered luminal stent migration in the upper GI tract. Gastrointest Endosc 78:787–793
doi: 10.1016/j.gie.2013.06.014
pubmed: 23871095
Jaganmohan S, Raju GS (2008) Tissue ingrowth in a fully covered self-expandable metallic stent (with videos). Gastrointest Endosc 68:602–604
doi: 10.1016/j.gie.2007.12.024
pubmed: 18331738
Wander P, Bartel MJ (2021) Endoscopic suturing device trapped in an esophageal stent: an adverse event and its resolution. Gastrointest Endosc 94:1143–1144
doi: 10.1016/j.gie.2021.08.003
pubmed: 34400130
Wadhwa RP, Kozarek RA, France RE, Brandabur JJ, Gluck M, Low DE, Traverso WL, Moonka R (2003) Use of self-expandable metallic stents in benign GI diseases. Gastrointest Endosc 58:207–212
doi: 10.1067/mge.2003.343
pubmed: 12872087
Chandrasekhara V, Topazian M, Abu Dayyeh BK, Levy MJ (2018) Re-deployment of a dislodged lumen-apposing metal stent (LAMS): avoiding the sacrificial LAMS. Endoscopy 50:E233-e234
doi: 10.1055/a-0624-1576
pubmed: 29920610
Gulati R, Rustagi T (2021) Endoscopic removal and replacement of the same lumen-apposing metal stent for multiple endoscopic necrosectomy sessions. Endoscopy 53:71–74
doi: 10.1055/a-1192-3219
pubmed: 32485748
Hallac A, Srikureja W, Liu E, Dhumal P, Thatte A, Puri N (2018) Economical effect of lumen apposing metal stents for treating benign foregut strictures. World J Gastroint Endosc 10:294–300
doi: 10.4253/wjge.v10.i10.294
Pasricha S, Li N, Bulsiewicz WJ, Rothstein RI, Infantolino A, Ertan A, Camara DS, Dellon ES, Triadafilopoulos G, Lightdale CJ, Madanick RD, Lyday WD, Muthusamy RV, Overholt BF, Shaheen NJ (2015) Sex and race and/or ethnicity differences in patients undergoing radiofrequency ablation for Barrett’s esophagus: results from the U.S. RFA Registry. Gastroint Endosc 82:276–284
doi: 10.1016/j.gie.2015.01.015